Datum: 24-12-2014
Baruch Fischhoff moderates a session in which a panel of academic, government and industry representatives discuss how GOF research could potentially benefit the acceleration of vaccine and antiviral development. The panel includes Philip Dormitzer (synthetic influenza vaccine viruses), Ralph Baric (vaccines targeting coronaviruses), Jerry Weir (regulatory perspective on viral manipulation for biologics), and Mark Denison (GOF research and countermeasures against SARS and MERS.)
Deel dit bericht
pageviews: 1808